COVID-19
FDA Grants Emergency Use Authorization for Northeastern University SARS-CoV-2 Test
The RT-PCR-based test was developed by Northeastern University's Life Sciences Testing Center.
FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants
The agency is requiring test developers to monitor emerging mutations and their potential impact on the performance of authorized SARS-CoV-2 tests.
OraSure Technologies Nabs $13.6M BARDA Funding
The funding will support OraSure's efforts to obtain 510(k) clearance and CLIA waiver for the InteliSwab rapid SARS-CoV-2 antigen test.
LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit
The CE-marked version of the kit includes expanded RSV target regions for increased compatibility with commercially available assays.
US DoD Awards Celltrion, Abbott Contracts for SARS-CoV-2 POC Rapid Antigen Tests
Celltrion will supply its DiaTrust tests to support military bases, long-term care facilities, community testing sites, and other designated places weekly.
Sep 23, 2021
Sep 22, 2021
Sep 16, 2021
Hong Kong-Based Prenetics to go Public via SPAC
Sep 15, 2021
Sep 13, 2021
Sep 9, 2021